| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/02/1998 | WO1998013506A1 Binary methods of increasing accumulation of essential amino acids in seeds |
| 04/02/1998 | WO1998013505A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
| 04/02/1998 | WO1998013504A1 Process for producing plants with female sterility |
| 04/02/1998 | WO1998013503A1 A plant and method of modification |
| 04/02/1998 | WO1998013502A2 Method to identify compounds for disrupting protein/protein interactions |
| 04/02/1998 | WO1998013501A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | WO1998013500A2 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013498A1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/02/1998 | WO1998013497A1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013495A1 Human rantes mutants incapable of aggregate formation |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/02/1998 | WO1998013490A2 A gene related to migraine in man |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013488A2 Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease |
| 04/02/1998 | WO1998013487A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013486A1 Novel genes associated with enhanced disease resistance in plants |
| 04/02/1998 | WO1998013485A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013478A2 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | WO1998013476A1 Transgenic model for heart failure |
| 04/02/1998 | WO1998013473A1 Genetically engineered yeast with modified signal peptidase complex |
| 04/02/1998 | WO1998013472A1 Methods for the production of bacteria containing eukaryotic genes |
| 04/02/1998 | WO1998013388A1 Antibody against human parathormone related peptides |
| 04/02/1998 | WO1998013387A1 Stabilized proteinaceous protease inhibitors and variants thereof |
| 04/02/1998 | WO1998013386A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | WO1998013383A1 Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | WO1998013353A1 Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and use for cellular assays in drug discovery |
| 04/02/1998 | WO1998013072A1 Compositions for and methods of treating multiple drug resistance |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013070A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | WO1998013026A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 04/02/1998 | WO1998012913A1 Expression of globin proteins in plants |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | WO1998007878A3 Long-term expression of gene products by transforming muscle cells |
| 04/02/1998 | WO1998007834A3 Materials and methods for increasing corn seed weight |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | WO1997027331A3 Methods and compositions for determining the sequence of nucleic acid molecules |
| 04/02/1998 | WO1997027325A3 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| 04/02/1998 | DE19639463A1 Verfahren zur Herstellung weiblich steriler Pflanzen A process for producing female-sterile plants |
| 04/02/1998 | CA2409901A1 Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and use for cellular assays in drug discovery |
| 04/02/1998 | CA2268945A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 04/02/1998 | CA2268265A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2267667A1 Bacillus thuringiensis cryet29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 04/02/1998 | CA2267666A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | CA2267221A1 A gene related to migraine in man |
| 04/02/1998 | CA2266905A1 Methods for the production of bacteria containing eukaryotic genes |
| 04/02/1998 | CA2266855A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 04/02/1998 | CA2266847A1 Compositions and methods for enhancing hybridization specificity |
| 04/02/1998 | CA2266846A1 Hex ii tumor-specific promoter and uses thereof in cancer therapy |
| 04/02/1998 | CA2266744A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | CA2266626A1 Expression of globin proteins in plants |
| 04/02/1998 | CA2266619A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266423A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2266329A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 04/02/1998 | CA2266323A1 Stabilized proteinaceous protease inhibitors and variants thereof |
| 04/02/1998 | CA2265938A1 Process for producing plants with female sterility |
| 04/02/1998 | CA2265554A1 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | CA2265519A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
| 04/02/1998 | CA2264567A1 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/02/1998 | CA2236867A1 Method to identify compounds for disrupting protein/protein interactions |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832981A1 DNA sequences to target proteins to the mammary gland for efficient secretion |
| 04/01/1998 | EP0832980A1 Recombinant therapies for infection and hyperproliferative disorders |
| 04/01/1998 | EP0832979A1 Promoters |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832976A2 Thermostable DNA polymerase from bacillus pallidus |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832974A2 Alcohol-aldehyd-dehydrogenases |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832972A2 Cloning, expression and production of tasty peptides |
| 04/01/1998 | EP0832971A1 Adheson variants |
| 04/01/1998 | EP0832970A1 Process for producing nucleoside-5'-phosphate |
| 04/01/1998 | EP0832901A1 Antibodies to hepatitis G virus, and their diagnostic use to detect HGV, and as therapeutic agent |
| 04/01/1998 | EP0832897A2 Hydrated zirconium silicate composition for purification of nucleic acids |
| 04/01/1998 | EP0832300A1 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
| 04/01/1998 | EP0832299A1 Use of nucleic acid ligands in flow cytometry |
| 04/01/1998 | EP0832297A1 Methods and compositions for identifying osteogenic agents |
| 04/01/1998 | EP0832296A2 Enhancement of alkaline phosphatase with sds in chemiluminescent substrates and enzyme inhibition assays |
| 04/01/1998 | EP0832295A1 Method for screening for receptor agonists and antagonists |
| 04/01/1998 | EP0832294A1 PCR-BASED cDNA SUBTRACTIVE CLONING METHOD |
| 04/01/1998 | EP0832293A2 Method for detecting heat-resistant micro-organisms capable of contaminating certain food products |
| 04/01/1998 | EP0832291A1 Enzyme linked oligonucleotide assays (elonas) |
| 04/01/1998 | EP0832290A1 Universal primer sequence for multiplex dna amplification |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832288A1 Male infertility y-deletion detection with multiplex primer combinations |
| 04/01/1998 | EP0832287A1 Oligonucleotide tags for sorting and identification |
| 04/01/1998 | EP0832282A1 IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES |
| 04/01/1998 | EP0832280A2 Probe masking method of reducing background in an amplification reaction |